We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore the link between Rinvoq and acne, a potential side effect of this JAK inhibitor. Learn about symptoms, causes, diagnosis, and effective treatment options to manage drug-induced acne while on Rinvoq therapy. Consult your doctor for personalized advice.

Sleeping tablets can help manage insomnia and sleep disorders when used correctly. This guide explains types, benefits, risks, and safe usage tips for better sleep health.
April 11, 2026
Explore the short-term and long-term effects of Adderall on the brain, including its uses, side effects, risks of misuse, and the importance of medical supervision for safe and effective treatment.
April 1, 2026

Rinvoq (upadacitinib) is a targeted therapy known as a Janus kinase (JAK) inhibitor, widely prescribed for various inflammatory and autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, and Crohn's disease. By selectively blocking specific JAK pathways, Rinvoq aims to reduce inflammation and modulate the immune response, offering significant relief for patients grappling with chronic and often debilitating conditions. While its efficacy in managing these diseases is well-documented, like all powerful medications, Rinvoq is associated with a spectrum of potential side effects. Among these, skin manifestations, particularly acne, have been reported by some patients. This comprehensive article delves into the relationship between Rinvoq use and the development or exacerbation of acne, exploring why it occurs, what it looks like, and crucially, how it can be effectively managed to ensure patients continue to benefit from their treatment with minimal discomfort.
Rinvoq is an oral, selective and reversible inhibitor of Janus kinase (JAK) enzymes, particularly JAK1. The JAK-STAT pathway is a critical signaling mechanism involved in the immune system, mediating the effects of various cytokines that drive inflammation and immune responses. By inhibiting JAK1, Rinvoq interferes with the signaling of several pro-inflammatory cytokines, thereby dampening the inflammatory cascade. This targeted approach makes it effective in treating conditions where an overactive immune response plays a central role.
The emergence of acne as a side effect of JAK inhibitors, including Rinvoq, is a recognized phenomenon. Clinical trials and post-marketing surveillance have indicated that a subset of patients taking Rinvoq may experience acne, ranging from mild to severe. This isn't typical adolescent acne; it's often referred to as "JAK inhibitor-associated acne" or "drug-induced acne," and it has distinct characteristics and underlying mechanisms.
Before diving into Rinvoq-specific acne, it's helpful to briefly understand general acne vulgaris. Acne is a common skin condition that occurs when hair follicles become clogged with oil (sebum) and dead skin cells. This leads to the formation of pimples, blackheads, whiteheads, cysts, and nodules, most commonly on the face, neck, chest, back, and shoulders. Several factors contribute to its development:
Rinvoq-induced acne can manifest differently from conventional acne. Patients often report:
It's crucial for patients to monitor their skin closely and report any new or worsening acne to their healthcare provider.
The exact mechanisms by which JAK inhibitors like Rinvoq lead to acne are still being fully elucidated, but several hypotheses exist, primarily revolving around the drug's impact on the immune system and skin biology:
JAK inhibitors modulate cytokine pathways that are also involved in skin homeostasis and immune responses within the skin. It's thought that by inhibiting specific JAK pathways, Rinvoq might inadvertently:
While Rinvoq is selective for JAK1, no drug is entirely specific. There might be some off-target effects or complex interactions within the intricate network of immune pathways that inadvertently promote acne formation.
Not everyone on Rinvoq develops acne, suggesting that individual genetic predisposition, hormonal status, and baseline skin characteristics play a role in determining susceptibility.
Diagnosing Rinvoq-associated acne primarily involves a thorough clinical assessment by a healthcare provider, often a dermatologist. Key diagnostic steps include:
The temporal relationship between starting Rinvoq and the onset of acne is a strong indicator of drug-induced acne. No specific lab tests are typically needed to diagnose Rinvoq-associated acne itself, but blood tests might be performed to monitor Rinvoq's overall safety profile.
Managing Rinvoq-induced acne requires a tailored approach, often involving a combination of topical and oral therapies. The goal is to control breakouts while ensuring the patient can continue their primary treatment with Rinvoq if it is effective for their underlying condition. It is crucial to consult with your prescribing physician and a dermatologist to develop the most appropriate treatment plan.
In severe or recalcitrant cases of Rinvoq-induced acne that do not respond to dermatological treatments, the prescribing physician may consider:
Any changes to Rinvoq dosage or treatment regimen must only be made under the strict guidance of the prescribing specialist, weighing the benefits of Rinvoq for the primary condition against the burden of the side effect.
While it may not be entirely possible to prevent Rinvoq-associated acne in susceptible individuals, proactive measures can help minimize its severity and impact:
It's important to consult your healthcare provider if you develop acne while on Rinvoq, especially if:
Your prescribing specialist (e.g., rheumatologist, gastroenterologist, dermatologist) should be informed about all side effects, including acne, to ensure appropriate management and to determine if any adjustments to your Rinvoq therapy are necessary.
Experiencing acne as a side effect of a necessary medication can be frustrating and emotionally challenging. It's important to remember that you are not alone, and effective treatments are available. Here are some tips for living with Rinvoq-induced acne:
No, Rinvoq-associated acne is generally not permanent. It is a side effect of the medication. With appropriate treatment, the acne can be managed, and if Rinvoq is discontinued (under medical supervision), the acne typically resolves.
You should absolutely NOT stop taking Rinvoq or any prescribed medication without first consulting your doctor. Stopping Rinvoq abruptly can lead to a flare-up of your underlying autoimmune condition. Your doctor will weigh the benefits of Rinvoq for your primary condition against the severity and impact of the acne and discuss management options or alternative treatments.
Yes, besides acne, other skin-related side effects reported with Rinvoq and other JAK inhibitors can include folliculitis (inflammation of hair follicles), herpes zoster (shingles) reactivation, and sometimes rash or eczema-like lesions. Always report any new skin changes to your doctor.
If you have a history of acne, Rinvoq can potentially exacerbate it or trigger new breakouts. It's important to inform your doctor about any pre-existing skin conditions before starting Rinvoq.
The onset of Rinvoq-associated acne can vary. Some patients may notice changes within a few weeks or months of starting the medication, while for others, it might develop later. It can also appear after a dose increase.
While the role of diet in drug-induced acne is not as clearly established as in conventional acne, maintaining a healthy, balanced diet is always beneficial for overall skin health. Some individuals find that reducing high glycemic index foods or dairy products may help, but this should be discussed with a healthcare professional.
Rinvoq is a vital medication for many individuals living with chronic inflammatory and autoimmune conditions. While the emergence of acne as a side effect can be distressing, it is a recognized and manageable complication. Understanding the symptoms, potential causes, and available treatment options is the first step towards effective management. The most crucial message is to maintain open communication with your healthcare team – your prescribing specialist and a dermatologist – to develop a personalized strategy that balances the benefits of Rinvoq with the need to alleviate acne symptoms. With appropriate care and collaboration, patients can continue to achieve disease control while maintaining their skin health and quality of life.
Curious if Pepto-Bismol can help your stomach after drinking? We explore the potential risks and what the research says about mixing Pepto-Bismol and alcohol, plus safer alternatives for hangover relief.
April 1, 2026